EF

EQT Fund Management S.a r.l.

Concentrated strategyContrarianQuality / disciplined sizing

Total reported value

$1.0B

Reporting period: 2026-03-31 · Number of holdings: 5

EQT Fund Management S.a r.l. disclosed 5 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.0B and a quarterly turnover rate of 31.8%.

Personality snowflake

Concentration
100
Portfolio Stability
31.75
Momentum/Contrarian
0
Sector conviction
0
Diversification
10
Sizing Uniformity
89.02

Recent moves

  • Trim WAY

    0.0%　-$215.0M

  • Add OCS

    0.0%　$39.1M

  • Add EVMN

    0.0%　$28.9M

  • Add PHVS

    0.0%　$1.7M

  • New buy AGMB

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1WAYWaystar Holding CORPStock-Other58.77%-14.51%—
2OCSOculis Holding AGStock-Other15.37%+4.77%—
3EVMNEvommune INCStock-Other11.10%+3.51%—
4PHVSPharvaris N.V.Stock-Other9.48%+0.93%—
5AGMBAgomab Therapeutics NVStock-Other5.28%+5.28%NEW

Holding changes this quarter

EQT Fund Management S.a r.l.'s most significant position changes for 2026-03-31: New buy: Agomab Therapeutics NV (AGMB).

Position changes disclosed by EQT Fund Management S.a r.l. for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1OCSOculis Holding AG+4.8%—Unchanged
2EVMNEvommune INC+3.5%—Unchanged
3PHVSPharvaris N.V.+0.9%—Unchanged
4WAYWaystar Holding CORP-14.5%—Unchanged
5AGMBAgomab Therapeutics NV—NEWNew buy

FAQ

What is EQT Fund Management S.a r.l. and what type of investor is it?
EQT Fund Management S.a r.l. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $1.0B, spread across 5 disclosed positions.
What are EQT Fund Management S.a r.l.'s largest equity positions?
Based on the latest 13F filing, EQT Fund Management S.a r.l.'s top holdings by market value are: 1. Waystar Holding CORP (WAY) — $599.8M (58.8%) 2. Oculis Holding AG (OCS) — $156.9M (15.4%) 3. Evommune INC (EVMN) — $113.3M (11.1%) 4. Pharvaris N.V. (PHVS) — $96.7M (9.5%) 5. Agomab Therapeutics NV (AGMB) — $53.9M (5.3%)
What changes did EQT Fund Management S.a r.l. make in its most recent portfolio filing?
In the latest quarter, EQT Fund Management S.a r.l. was primarily adding exposure — initiating 1 new positions and adding to 0 existing holdings. The largest of these moves: New buy: Agomab Therapeutics NV (AGMB)
What sectors does EQT Fund Management S.a r.l. focus on?
Sector breakdown data is not yet available for EQT Fund Management S.a r.l.. Check back after the next 13F processing cycle.